Rule speeds approvals for ‘breakthrough’ devices, other commercially covered services

Why This Topic Matters

The rule may affect how quickly certain innovative devices and services become covered by Medicare and how coverage decisions are made in the near term. Readers involved in reimbursement, coverage policy, or device commercialization need to understand the policy framework and the pending guidance that will shape implementation.

Article Sections

1. Until it kicks in, stick to current regs

   Explains the timing of implementation and the interim status of current Medicare coverage processes while additional guidance is developed.

2. Enter the ‘breakthrough’ adoption

   Describes the new Medicare coverage pathway for innovative technologies and summarizes the broader policy context surrounding FDA breakthrough devices.